2,128
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Synthesis and evaluation of anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities of some 3H-quinazolin-4-one derivatives

, , , , , & show all
Pages 672-683 | Received 12 Dec 2018, Accepted 21 Jan 2019, Published online: 01 Mar 2019

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86.
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57–70.
  • Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007;26:1324–37.
  • Vogler M, Dinsdale D, Dyer MJS, Cohen GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 2009;16:360–7.
  • Soreide K, Janssen EA, Korner H, Baak JPA. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion and metastasis. J Pathol 2006;209:145–56.
  • Rakashanda S, Rana F, Rafiq S, et al. Role of proteases in cancer: a review. Biotechnol Mol Biol Rev 2012;7:90–101.
  • Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004;23:101–17.
  • Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin regulated dormant tumor phenotype. Cancer Cell 2006;10:355–62.
  • Ho AS, Chen CH, Cheng CC, et al. Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers. Oncotarget 2014;5:473–80.
  • Dennis EA, Cao J, Hsu YH, et al. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011;111:6130–85.
  • Luo C, Zhang H. The role of proinflammatory pathways in the pathogenesis of colitis-associated colorectal cancer. Mediators Inflamm 2017;2017:1.
  • Vulcan A, Manjer J, Ohlsson B. High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study. BMC Cancer 2017;17:842–9.
  • Ojo OA, Afon AA, Ojo AB, et al. Inhibitory effects of solvent-partitioned fractions of two nigerian herbs (spondias mombin linn. and mangifera indica L.) on α-amylase and α-glucosidase. Antioxidants 2018;7:73.
  • Li X, Meng X, Gao X, et al. Elevated serum xanthine oxidase activity is associated with the development of type 2 diabetes: a prospective cohort study. Diabetes Care 2018;41:88–890.
  • Kshirsagar UA. Recent developments in the chemistry of quinazolinone alkaloids. Org Biomol Chem 2015;13:9336–52.
  • Tiwary BK, Pradhan K, Nanda AK, Chakraborty R. Implication of quinazoline-4 (3H)-ones in medicinal chemistry: a brief review. J Chem Biol Ther 2015;1:1000104.
  • Vavsari VF, Ziarani GM. Synthesis of 4-quinazolinones by transition metal-catalyzed processes (microreview). Chem Heterocycl Comp 2018;54:317–9.
  • Ghorab MM, Alsaid MS, Soliman AM, Al-Mishari AA. Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors. J Enzyme Inhib Med Chem 2018;33:67–73.
  • Mekala N, Buddepu SR, Dehury SK, et al. A novel strategy for the manufacture of idelalisib: controlling the formation of an enantiomer. RSC Adv 2018;8:15863–9.
  • Seema R, Pathak Malhotra V, Nath R, et al. Synthesis and antihypertensive activity of novel quinazolin-4(3H)-one derivatives. Cent Nerv Syst Agents Med Chem 2014;14:34–8.
  • Al-Omar MA, El-Azab AS, El-Obeid HA, Abdel Hamide SG. Synthesis of some new 4-(3H)-quinazoline analogs as potential antioxidant agents. J Saudi Chem Soc 2006;10:113–30.
  • Jain N, Jaiswal J, Pathak A, Singour PK. Synthesis, molecular docking and evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one derivatives for their anticonvulsant activity. Cent Nerv Syst Agents Med Chem 2018;18:63–73.
  • Osarumwense PO, Edema MO, Usifoh O. Synthesis and anti-inflammatory activity of 4(3H)-quinazolinone and its 2-methyl and 2-phenyl-4 (3H)- quinazolinone derivatives. IOSR J Appl Chem 2018;11:12–5.
  • El-Sayed NN, Alafeefy AM, Bakht MA, et al. Synthesis, antiphospholipase A2, antiprotease, antibacterial evaluation and molecular docking analysis of certain novel hydrazones. Molecules 2016;21:1664–80.
  • El-Sayed NN, Al-Balawi NA, Alafeefy AM, et al. Synthesis, characterization and antimicrobial evaluation of some thiazole-derived carbamates, semicarbazones, amides and carboxamide. J Chem Soc Pak 2016;38:358–68.
  • Nagase T, Mizutani T, Ishikawa S, et al. Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists. J Med Chem 2008;51:4780–9.
  • Nagase T, Mizutani T, Sekino E, et al. structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists. J Med Chem 2008;51:6889–901.
  • Kumar S, Kaur H, Singh I, et al. Synthesis, characterization and biological activity of various substituted quinazolinone derivatives containing dopamine moiety. World J Chem 2009;4:195–200.
  • Kumar P, Shrivastava B, Stables JP, Pandeya SN. Design, synthesis and potential 6 Hz psychomotor seizure test activity of some novel 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one. Eur J Med Chem 2011;46:1006–18.
  • Kumar A, Singh S, Saxena AK, Shanker K. Synthesis of quinazolinyl pyrimidinediones and their anti-inflammatory activity. Indian J Chem 1988;27B:443–7.
  • Kim H, Lee HJ, Kim DP. Integrated one-flow synthesis of heterocyclic thioquinazolinones through serial microreactions with two organolithium intermediates. Angew Chem Int Ed Engl 2015;54:1877–80.
  • van Zyl EF. A survey of reported synthesis of methaqualone and some positional and structural isomers. Forensic Sci Int 2001;122:142–9.
  • Soliman FSG, Shafik RM, Elnenaey EA. Synthesis of methaqualone and its diphasic titration in pure and tablet forms. J Pharm Sci 1978;67:411–3.
  • Rajasekaran S, GopalKrishna R, Sanjay PPN. Gurpreet SS. Synthesis, antibacterial and in vitro antioxidant activity of 2,3-substituted quinazolin-4(3H)-ones. J Chem Pharm Res 2010;2:482–8.
  • El-Baih FEM, Al-Blowy HAS, Al-Hazimi HM. Synthesis of some thienopyrimidine derivatives. Molecules 2006;11:498–513.
  • Dineen TA, Zajac MA, Myers AG. Efficient transamidation of primary carboxamides by in situ activation with N,N-dialkylformamide dimethyl acetals. J Am Chem Soc 2006;128:16406–9.
  • Reilly TJ. The preparation of lidocaine. J Chem Educ 1999; 76:1557.
  • Lofgren NM, Lundquist BJ. Alkyl glycinanilides, Patent 2441498A, USA; 1948.
  • Salman AS, Abdel-Aziem A, Alkubbat MJ. Design, synthesis of some new thio-substituted imidazole and their biological activity. Am J Org Chem 2015;5:57–72.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983;65:55–63.
  • Al-Khayal K, Alafeefy A, Vaali-Mohammed MA, et al. Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration. BMC Cancer 2017;17:4–15.
  • Lôbo de Araújo A, Radvanyi F. Determination of phospholipase A2 activity by a colorimetric assay using a pH indicator. Toxicon 1987;25:1181–8.
  • Kunitz M. Crystalline soyabean trypsin inhibitor: II. General properties. J Gen Physiol 1947;30:291–310.
  • Subramanian R, Asmawi MZ, Sadikun A. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim Pol 2008;55:391–8.
  • Andrade-Cetto A, Becerra-Jiménez J, Cardenas VR. Alfa-glucosidase-inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes. J Ethnopharmacol 2008;116:27–32.
  • Bondet V, Brand-Williams W, Berset C. Kinetics and mechanisms of antioxidant activity using the DPPH• free radical method.  LWT Food Sci Technol 1997;30:609–15.
  • Zolfagharian H, Mohajeri M, Babaie M. Honey bee venom (Apis mellifera) contains anticoagulation factors and increases the blood-clotting time. J Pharmacopuncture 2015;18:7–11.
  • Wacklin H. Interfacial mechanism of phospholipase A2: pH-dependent inhibition and ME-B-cyclodextrin activation. Biochemistry 2009;48:5874–81.